Update on nutrients involved in maintaining healthy bone

Endocrinologia y Nutricion

Volumn 60, Issue 4, 2013, Pages 197-210

  Rondanelli, Mariangela ^a   Opizzi, Annalisa ^a   Perna, Simone ^a   Faliva, Milena Anna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Aging; Bone; Nutrients; Osteopenia; Osteoporosis

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; ARGININE; ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BORON; CALCIUM; CITRATE POTASSIUM; COLECALCIFEROL; COPPER; CYANOCOBALAMIN; FARNOQUINONE; FOLIC ACID; LONG CHAIN FATTY ACID; MAGNESIUM; PHYTOMENADIONE; PLACEBO; POLYUNSATURATED FATTY ACID; POTASSIUM; PROLINE; PYRIDOXINE; QUERCETIN; RIBOFLAVIN; SELENIUM; SILICON; STRONTIUM; VITAMIN B GROUP; VITAMIN D; VITAMIN K GROUP; ZINC;

ANTIOXIDANT ACTIVITY; BONE; BONE DENSITY; BONE GROWTH; BONE MATURATION; BONE STRENGTH; CALCIFICATION; COST EFFECTIVENESS ANALYSIS; DIETARY INTAKE; DRUG MECHANISM; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; VITAMIN SUPPLEMENTATION;

AMINO ACIDS; ASCORBIC ACID; FOOD; HUMANS; MINERALS; OSTEOPOROSIS; PROTEINS; VITAMIN B COMPLEX; VITAMIN K;

EID: 84875892486     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2012.09.006     Document Type: Short Survey

References (162)

1. Looker A.C., Orwoll E.S., Johnston C.C.JJr., Lindsay R.L., Wahner H.W., Dunn W.L., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997, 12:1761-1768.
2. Haczynski J., Jakimiuk A. Vertebral fractures: a hidden problem of osteoporosis. Med Sci Monit 2001, 7:1108-1117.
3. http://www.statistics.gov.uk/.
4. Kanis J.A., Johnell O., Oden A., Jonsson B., De Laet C., Dawson A. Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 2000, 27:585-590.
5. Cauley J.A., Thompson D.E., Ensrud K.C., Scott J.C., Black D. Risk of mortality following clinical fractures. Osteoporosis Int 2000, 11:556-561.
6. Johnell O., Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006, 17:1726-1733.
7. Kanis J.A., Johnell O. Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 2005, 16:229-238.
8. Pazianas M., Miller P., Blumentals W.A., Bernal M., Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007, 29:1548-1558.
9. Banks E., Canfell K. Invited Commentary: Hormone therapy risks and benefits - the Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am J Epidemiol 2009, 170:24-28.
10. Kraft K. Complementary/alternative medicine in the context of prevention of disease and maintenance of health. Prev Med 2009, 49:88-92.
11. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293:2257-2264.
12. Kitchin B., Morgan S.L. Not just calcium and vitamin D: other nutritional considerations in osteoporosis. Curr Rheumatol Rep 2007, 9:85-92.
13. Palacios C. The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr 2006, 46:621-628.
14. Miggiano G.A., Gagliardi L. Diet, nutrition and bone health. Clin Ter 2005, 156:47-56.
15. Heaney R.P. The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res 1994, 9:1515-1523.
16. New S.A., Bolton-Smith C., Grubb D.A., Reid D.M. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr 1997, 65:1831-1839.
17. Freudenheim J.L., Johnson N.E., Smith E.L. Relationships between usual nutrient intake and bone-mineral content of women 35-65 years of age: longitudinal and cross-sectional analysis. Am J Clin Nutr 1986, 44:863-876.
18. Hall S.L., Greendale G.A. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int 1998, 63:183-189.
19. Ilich J.Z., Brownbill R.A., Tamborini L. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 2003, 57:554-565.
20. Roughead Z.K., Kunkel M.E. Effect of diet on bone matrix constituents. J Am Coll Nutr 1991, 10:242-246.
21. Franceschi R.T. The role of ascorbic acid in mesenchymal differentiation. Nutr Rev 1992, 50:65-70.
22. Morton D.J., Barrett-Connor E.L., Schneider D.L. Vitamin C supplement use and bone mineral density in postmenopausal women. J Bone Miner Res 2001, 16:135-140.
23. Leveille S.G., LaCroix A.Z., Koepsell T.D., Beresford S.A., Van Belle G., Buchner D.M. Dietary vitamin C and bone mineral density in postmenopausal women in Washington State, USA. J Epidemiol Community Health 1997, 51:479-485.
24. Sahni S., Hannan M.T., Gagnon D., Blumberg J., Cupples L.A., Kiel D.P., et al. Protective effect of total and supplemental vitamin C intake on the risk of hip fracture - a 17-year follow-up from the Framingham Osteoporosis Study. Osteoporos Int 2009, 20:1853-1861.
25. Masse P.G., Jougleux J.L., Tranchant C., Dosy J., Caissie M., P Coburn S. Enhancement of calcium/vitamin d supplement efficacy by administering concomitantly three key nutrients essential to bone collagen matrix for the treatment of osteopenia in middle-aged women: a one-year follow-up. J Clin Biochem Nutr 2010, 46:20-29.
26. Ruiz-Ramos M., Vargas L.A., Fortoul Van der Goes T.I., Cervantes-Sandoval A., Mendoza-Nunez V.M. Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly. J Nutr Health Aging 2010, 14:467-472.
27. Arslan A., Orkun S., Aydin G., Keles I., Tosun A., Arslan M., et al. Effects of ovariectomy and ascorbic acid supplement on oxidative stress parameters and bone mineral density in rats. Libyan J Med 2011, 6. Epub 2011 Oct 3. 10.3402/ljm.v6i0.5965.
28. Diplock A.T. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1991, 53:189S-193S.
29. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990, 85:632-639.
30. Pearson D.A. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract 2007, 22:517-544.
31. Chan R., Leung J., Woo J. No Association between dietary vitamin K intake and fracture risk in chinese community-dwelling older men and women: a prospective study. Calcif Tissue Int 2012, 90:396-403.
32. Booth S.L., Broe K.E., Gagnon D.R., Tucker K.L., Hannan M.T., McLean R.R., et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 2003, 77:512-516.
33. Iwamoto I., Kosha S., Noguchi S., Murakami M., Fujino T., Douchi T., et al. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas 1999, 31:161-164.
34. Iwamoto J., Takeda T., Ichimura S. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci 2000, 5:546-551.
35. Cheung A.M., Tile L., Lee Y., Tomlinson G., Hawker G., Scher J., et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 2008, 5:e196.
36. Stevenson M., Lloyd-Jones M., Papaioannou D. Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol Assess 2009, 13:1-134.
37. Vermeer C. Vitamin K: the effect on health beyond coagulation - an overview. Food Nutr Res 2012, 56. Epub 2012 Apr 2. 10.3402/fnr.v56i0.5329.
38. Gajic-Veljanoski O., Bayoumi A.M., Tomlinson G., Khan K., Cheung A.M. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?. Osteoporos Int 2012, 23:2681-2692.
39. Esmon C.T., Suttie J.W., Jackson C.M. The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin. J Biol Chem 1975, 250:4095-4099.
40. Binkley N.C., Suttie J.W. Vitamin K nutrition and osteoporosis. J Nutr 1995, 125:1812-1821.
41. Booth S.L., Gundberg C.M., McKeown N.M., Morse M.O., Wood R.J. Vitamin K depletion increases bone turnover. J Bone Miner Res 1999, 14:S393.
42. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382:448-452.
43. Weber P. The role of vitamins in the prevention of osteoporosis - a brief status report. Int J Vitam Nutr Res 1999, 69:194-197.
44. Iwamoto J., Takeda T., Sato Y. Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis. Nutr Rev 2006, 64:509-517.
45. Yazdanpanah N., Zillikens M.C., Rivadeneira F., de Jong R., Lindemans J., Uitterlinden A.G., Pols H.A., van Meurs J.B. Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: the Rotterdam study. Bone 2007, 41:987-994.
46. Holstein J.H., Herrmann M., Splett C., Herrmann W., Garcia P., Histing T., et al. Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. Am J Clin Nutr 2009, 90:1440-1445.
47. Masse P.G., Rimnac C.M., Yamauchi M., Coburn S.P., Rucker R.B., Howell D.S., Boskey A.L. Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone 1996, 18:567-574.
48. 6 deficient. Acta Orthop Scand 1992, 63:635-638.
49. Herrmann M., Widmann T., Colaianni G., Colucci S., Zallone A., Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005, 51:2348-2353.
50. Herrmann M., Peter Schmidt J., Umanskaya N., Wagner A., Taban-Shomal O., Widmann T., et al. The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 2007, 45:1621-1632.
51. Bucciarelli P., Martini G., Martinelli I., Ceccarelli E., Gennari L., Bader R., et al. The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. Eur J Intern Med 2010, 21:301-305.
52. Gjesdal C.G., Vollset S.E., Ueland P.M., Refsum H., Drevon C.A., Gjessing H.K., et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 2006, 166:88-94.
53. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999, 19:217-246.
54. Herrmann W., Herrmann M., Obeid R. Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 2007, 8:17-31.
55. Mudd S.H., Skovby F., Levy H.L., Pettigrew K.D., Wilcken B., Pyeritz R.E., et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985, 37:1-31.
56. Lubec B., Fang-Kircher S., Lubec T., Blom H.J., Boers G.H. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996, 1315:159-162.
57. Khan M., Yamauchi M., Srisawasdi S., Stiner D., Doty S., Paschalis E.P., et al. Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. Bone 2001, 28:387-398.
58. Clarke R., Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 2000, 26:341-348.
59. Cagnacci A., Baldassari F., Rivolta G., Arangino S., Volpe A. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 2003, 33:956-959.
60. McLean R.R., Karasik D., Selhub J., Tucker K.L., Ordovas J.M., Russo G.T., et al. Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 2004, 19:410-418.
61. van Wijngaarden J.P., Dhonukshe-Rutten R.A., van Schoor N.M., van der Velde N., Swart K.M., Enneman A.W., et al. Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr 2011, 11:80.
62. Tranquilli A.L., Lucino E., Garzetti G.G., Romanini C. Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women. Gynecol Endocrinol 1994, 8:55-58.
63. Price C.T., Langford J.R., Liporace F.A. Essential nutrients for bone health and a review of their availability in the average North American Diet. Open Orthop 2012, 6:143-149.
64. Zofkova I., Kancheva R.L. The relationship between magnesium and calciotropic hormones. Magnes Res 1995, 8:77-84.
65. Targovnik J.H., Rodman J.S., Sherwood L.M. Regulation of parathyroid hormone secretion in vitro: quantitative aspects of calcium and magnesium ion control. Endocrinology 1971, 88:1477-1482.
66. Carpenter T.O., Mackowiak S.J., Troiano N., Gundberg C.M. Osteocalcin and its message: relationship to bone histology in Mg-deprived rats. Am J Physiol 1992, 263:E106-E114.
67. Jones J.E., Schwartz R., Krook L. Calcium homeostasis and bone pathology in magnesium deficient rats. Calcif Tissue Int 1980, 31:231-238.
68. Gruber H.E., Massry S.G., Brautbar N. Effect of relatively long-term hypomagnesemia on the chondro-osseous features of the rat vertebrae. Miner Electrolyte Metab 1994, 20:282-286.
69. Boskey A.L., Rimnac C.M., Bansal M., Federman M., Lian J., Boyan B.D. Effect of short-term hypomagnesemia on the chemical and mechanical properties of rat bone. J Orthop Res 1992, 10:774-783.
70. Kenney M.A., McCoy H., Williams L. Effects of magnesium deficiency on strength, mass and composition of rat femur. Calcif Tissue Int 1994, 54:44-49.
71. Miller E.R., Ullrey D.E., Zutaut C.L., Baltzer B.V., Schmidt D.A., Hoefer J.A., et al. Magnesium requirement of the baby pig. J Nutr 1965, 85:13-20.
72. Stendig-Lindberg G., Tepper R., Leichter I. Trabecular bone density in a two-year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993, 6:155-163.
73. Sojka J.E., Weaver C.M. Magnesium supplementation osteoporosis. Nutr Rev 1995, 53:71-74.
74. Durlach J., Durlach V., Bac P., Rayssiguier Y., Bara M., Guiet-Bara A., et al. Magnesium and ageing II. Clinical data: aetiological mechanisms and pathophysiological consequences of magnesium deficit in the elderly. Magnes Res 1993, 6:379-394.
75. Reginster J.Y., Strause L., Deroisy R., Lecart M.P., Saltman P., Franchimont P. Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Magnesium 1989, 8:106-109.
76. Hallfrisch J., Muller D.C. Does diet provide adequate amounts of calcium, iron, magnesium, and zinc in a well-educated adult population?. Exp Gerontolnm 1993, 28:473-483.
77. Genuis S.J., Bouchard T.P. Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention. J Environ Public Health 2012, 2012:354151.
78. Vormann J. Magnesium: nutrition and metabolism. Mol Aspects Med 2003, 24:27-37.
79. Farrell V.A., Harris M., Lohman T.G., Going S.B., Thomson C.A., Weber J.L., et al. Comparison between dietary assessment methods for determining associations between nutrient intakes and bone mineral density in postmenopausal women. J Am Diet Assoc 2009, 109:899-904.
80. Vescini F., Buffa A., La Manna G., Ciavatti A., Rizzoli E., Bottura A., et al. Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers. J Endocrinol Invest 2005, 28:218-222.
81. Sakhaee K., Maalouf N.M., Abrams S.A., Pak C.Y. Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women. J Clin Endocrinol Metab 2005, 90:3528-3533.
82. Yamaguchi M. Role of zinc in bone formation and bone resorption. J Trace Elem Exp Med 1998, 11:119-135.
83. Rossi L., Migliaccio S., Corsi A., Marzia M., Bianco P., Teti A., et al. Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition. J Nutr 2001, 131:1142-1146.
84. Cerklewski F.L., Forbes R.M. Influence of dietary zinc on lead toxicity in the rat. J Nutr 1976, 106:689-696.
85. Flora S.J., Kumar D., Das Gupta S. Interaction of zinc, methionine or their combination with lead at gastrointestinal or post-absorptive level in rats. Pharmacol Toxicol 1991, 68:3-7.
86. Miller G.D., Massaro T.F., Massaro E.J. Interactions between lead and essential elements: a review. Neurotoxicology 1990, 11:99-120.
87. Nielsen F.H., Lukaski H.C., Johnson L.K., Roughead Z.K. Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women. Br J Nutr 2011, 106:1872-1879.
88. Kaats G.R., Preuss H.G., Croft H.A., Keith S.C., Keith P.L. A comparative effectiveness study of bone density changes in women over 40 following three bone health plans containing variations of the same novel plant-sourced calcium. Int J Med Sci 2011, 8:180-191.
89. Armstrong T.A., Spears J.W. Effect of dietary boron on growth performance, calcium and phosphorus metabolism, and bone mechanical properties in growing barrows. J Anim Sci 2001, 79:3120-3127.
90. Hunt C.D. The biochemical effects of physiologic amounts of dietary boron in animal nutrition models. Environ Health Perspect 1994, 102(Suppl. 7):35-43.
91. Carlisle E.M. Silicon: a possible factor in bone calcification. Science 1970, 167:279-280.
92. Carlisle E.M. Silicon: an essential element for the chick. Science 1972, 178:619-621.
93. Schwarz K., Milne D.B. Growth-promoting effects of silicon in rats. Nature 1972, 239:333-334.
94. Kim M.H., Bae Y.J., Choi M.K., Chung Y.S. Silicon supplementation improves the bone mineral density of calcium-deficient ovariectomized rats by reducing bone resorption. Biol Trace Elem Res 2009, 128:239-247.
95. Beck G.R., Ha S.W., Camalier C.E., Yamaguchi M., Li Y., Lee J.K., et al. Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo. Nanomedicine 2012, 8:793-803.
96. Jugdaohsingh R., Tucker K.L., Qiao N., Cupples L.A., Kiel D.P., Powell J.J. Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort. J Bone Miner Res 2004, 19:297-307.
97. Eisinger J., Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnes Res 1993, 6:247-249.
98. Spector T.D., Calomme M.R., Anderson S.H., Clement G., Bevan L., Demeester N., et al. Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial. BMC Musculoskelet Disord 2008, 9:85.
99. Kelsay J.L., Behall K.M., Prather E.S. Effect of fiber from fruits and vegetables on metabolic responses of human subjects. II. Calcium, magnesium, iron, and silicon balances. Am J Clin Nutr 1979, 32:1876-1880.
100. Giammarioli S., Mosca M., Sanzini E. Silicon content of Italian mineral waters and its contribution to daily intake. J Food Sci 2005, 70:S509-S512.
101. Bellia J., Birchall J.D., Roberts N.B. Beer a dietary source of silicon. Lancet 1994, 343:235.
102. Jugdaosingh R., Anderson S.H.C., Tucker K.L., Elliott H., Kiel D.P., Thompson R.P., et al. Dietary silicon intake and absorption. Am J Clin Nutr 2002, 75:887-893.
103. McNaughton S., Bolton-Smith C., Mishra G.D., Jugdaosingh R., Powell J.J. Dietary silicon intake in post-menopausal women. Br J Nutr 2005, 94:813-817.
104. Jesudason D., Clifton P. The interaction between dietary protein and bone health. J Bone Miner Metab 2011, 29:1-14.
105. Meng X., Zhu K., Devine A., Kerr D.A., Binns C.W., Prince R.L. A 5-year cohort study of the effects of high protein intake on lean mass and BMC in elderly postmenopausal women. J Bone Miner Res 2009, 24:1827-1834.
106. Kerstetter J.E., O'Brien K.O., Insogna K.L. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr 2003, 133:855S-861S.
107. Hegsted M., Schuette S.A., Zemel M.B., Linkswiler H.M. Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake. J Nutr 1981, 111:553-562.
108. Zemel M.B. Calcium utilization: effect of varying level and source of dietary protein. Am J Clin Nutr 1988, 48(Suppl. 3):880-883.
109. Barzel U.S., Massey L.K. Excess dietary protein can adversely affect bone. J Nutr 1998, 128:1051-1053.
110. Heaney R.P. Excess dietary protein may not adversely affect bone. J Nutr 1998, 128:1054-1057.
111. Massey L.K. Does excess dietary protein adversely affect bone? Symposium overview. J Nutr 1998, 128:1048-1050.
112. Schuette S.A., Hegsted M., Zemel M.B., Linkswiler H.M. Renal acid, urinary cyclic AMP, and hydroxyproline excretion as affected by level of protein, sulfur amino acid, and phosphorus intake. J Nutr 1981, 111:2106-2116.
113. Zemel M.B., Schuette S.A., Hegsted M., Linkswiler H.M. Role of the sulfur-containing amino acids in protein-induced hypercalciuria in men. J Nutr 1981, 111:545-552.
114. Itoh R., Nishiyama N., Suyama Y. Dietary protein intake and urinary excretion of calcium: a cross-sectional study in a healthy Japanese population. Am J Clin Nutr 1998, 67:438-444.
115. Kerstetter J.E., O'Brien K.O., Caseria D.M., Wall D.E., Insogna K.L. The impact of dietary protein on calcium absorption and kinetic measures of bone turnover in women. J Clin Endo Metab 2005, 90:26-31.
116. Chevalley T., Rizzoli R., Manen D., Caverzasio J., Bonjour J.P. Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells. Bone 1998, 23:103-109.
117. Parto K., Penttinen R., Paronen I., Pelliniemi L., Simell O. Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis 1993, 16:50.
118. Oxlund H., Barckman M., Ortoft G., Andreassen T.T. Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 1995, 17(Suppl. 4):365S-371S.
119. Yakar S., Canalis E., Sun H., Mejia W., Kawashima Y., Nasser P., et al. Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Min Res 2009, 24:1481-1492.
120. Kerstetter J.E., O'Brien K.O., Insogna K.L. Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr 2003, 78(Suppl. 3):584S-592S.
121. Hannan M.T., Felson D.T., Dawson-Hughes B., Tucker K.L., Cupples L.A., Wilson P.W., et al. Risk factors for longitudinal bone loss in elderly men and wom the Framingham Osteoporosis Study. J Bone Miner Res 2000, 15:710-720.
122. Visser J.J., Hoekman K. Arginine supplementation in the prevention and treatment of osteoporosis. Med Hypotheses 1994, 43:339-342.
123. Fiore C.E., Pennisi P., Cutuli V.M., Prato A., Messina R., Clementi G. l-Arginine prevents bone loss and bone collagen breakdown in cyclosporine A-treated rats. Eur J Pharmacol 2000, 408:323-326.
124. Pennisi P., D'Alcamo M.A., Leonetti C., Clementi A., Cutuli V.M., Riccobene S., et al. Supplementation of l-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model. J Bone Miner Metab 2005, 23:134-139.
125. Pennisi P., Clementi G., Prato A., Luca T., Martinez G., Mangiafico R.A., et al. l-Arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats. J Endocrinol Invest 2009, 32:546-551.
126. Kamps N., Gerzer R., Heer M. Effects of l-arginine supplementation on bone metabolism. J Gravit Physiol 2002, 9:P179-P180.
127. Baecker N., Boese A., Schoenau E., Gerzer R., Heer M. l-Arginine, the natural precursor of NO, is not effective for preventing bone loss in postmenopausal women. J Bone Miner Res 2005, 20:471-479.
128. Hurson M., Regan M., Kirk S., Wasserkrug H., Barbul A. Metabolic effects of arginine in a healthy elderly population. J Parenter Enteral Nutr 1995, 19:227-230.
129. Baker T.A., Milstien S., Katusic Z.S. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 2001, 37:333-338.
130. De Marchi S., Prior M., Rigoni A., Zecchetto S., Rulfo F., Arosio E. Ascorbic acid prevents vascular dysfunction induced by oral glucose load in healthy subjects. Eur J Intern Med 2012, 23:54-57.
131. Huang A., Vita J.A., Venema R.C., Keaney J.F. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000, 275:17399-17406.
132. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayeri G., Werneri E.R. l-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001, 276:40-47.
133. D'Uscio L., Milstien S., Richardson D., Smith L., Katusic Z.S. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase Activity. Circ Res 2003, 92:88-95.
134. EFSA J 2010, 8:1814.
135. Hinoi E. Functional glutamate signaling in bone. Yakugaku Zasshi 2010, 130:1175-1179.
136. Li J.L., Zhao L., Cui B., Deng L.F., Ning G., Liu J.M. Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-d-aspartate receptors activation in vitro. Acta Pharmacol Sin 2011, 32:895-903.
137. Willoughby D.A., Moore A.R., Colville-Nash P.R. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 2000, 355:646-648.
138. KrugerMC, Horrobin D.F. Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res 1997, 36:131-151.
139. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382.
140. Weiss L.A., Barrett-Connor E., von Mühlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 2005, 81:934-938.
141. Salari P., Rezaie A., Larijani B., Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 2008, 14:RA37-RA44.
142. Farina E.K., Kiel D.P., Roubenoff R., Schaefer E.J., Cupples L.A., Tucker K.L. Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 2011, 93:1142-1151.
143. Griel A.E., Kris-Etherton P.M., Hilpert K.F., Zhao G., West S.G., Corwin R.L. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 2007, 6:2.
144. Kruger M.C., Coetzer H., de Winter R., Gericke G., van Papendorp D.H. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 1998, 10:385-394.
145. Vanlint S.J., Ried K. Efficacy and tolerability of calcium, vitamin D and a plant-based omega-3 oil for osteopenia: a pilot RCT. Maturitas 2012, 71:44-48.
146. Orchard T.S., Pan X., Cheek F., Ing S.W., Jackson R.D. A systematic review of omega-3 fatty acids and osteoporosis. Br J Nutr 2012, 107(Suppl. 2):S253-S260.
147. Cao J.J., Gregoire B.R., Zeng H. Selenium deficiency decreases antioxidative capacity and is detrimental to bone microarchitecture in mice. J Nutr 2012, 142:1526-1531.
148. Zhang J., Munger R.G., West N.A., Cutler D.R., Wengreen H.J., Corcoran C.D. Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status. Am J Epidemiol 2006, 163:9-17.
149. Melhus H., Michaelsson K., Holmberg L., Wolk A., Ljunghall S. Smoking, antioxidant vitamins, and the risk of hip fractures. J Bone Miner Res 1999, 14:129-135.
150. Wolf R.L., Cauley J.A., Pettinger M., Jackson R., Lacroix A., Leboff M.S., et al. Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative. Am J Clin Nutr 2005, 82:581-588.
151. Riyat M., Sharma D.C. An experimental study of the effect of strontium pre-treatment on calcium release from carious and non-carious teeth. Biol Trace Elem Res 2010, 133:251-254.
152. Cabrera W.E., Schrooten I., De Broe M.E., D'Haese P.C. Strontium and bone. J Bone Min Res 1999, 14:661-668.
153. Grynpas M.D., Marie P.J. Effects of low doses of strontium on bone quality and quantity in rats. Bone 1990, 11:313-319.
154. Marie P.J., Garba M.T., Hott M., Miravet L. Effect of low doses of stable strontium on bone metabolism in rats. Miner Electrolyte Metab 1985, 11:5-13.
155. Skoryna S.C. Metabolic aspects of the pharmacologic uses of trace elements in human subjects with specific references to stable strontium. Trace substances in environmental health-XVIII 1992, 3-23. B.D. Beck (Ed.).
156. Aaseth J., Boivin G., Andersen O. Osteoporosis and trace elements - an overview. J Trace Elem Med Biol 2012, 26:149-152.
157. Saltman P.D., Strause L.G. The role of trace minerals in osteoporosis. J Am Coll Nutr 1993, 12:384-389.
158. Buck B.C., Ulrich R., Taube V., Jacobsen B., Ganter M. Osteopenia as a result of copper deficiency in a dwarf Thuringian Forest goat. Tierarztl Prax Ausg G Grosstiere Nutztiere 2012, 40:45-52.
159. Kanis J.A., Burlet N., Cooper C., Delmas P.D., Reginster J.Y., Borgstrom F., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008, 19:399-428.
160. Engelke K., Kemmler W., Lauber D., Beeskow C., Pintag R., Kalender W.A. Exercise maintains bone density at spine and hip EFOPS: a 3-year longitudinal study in early postmenopausal women. Osteoporos Int 2006, 17:133-142.
161. Howe T.E., Shea B., Dawson L.J., Downie F., Murray A., Ross C., Harbour R.T., Caldwell L.M., Creed G., et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2011, 6:CD000333.
162. Gregg E.W., Pereira M.A., Caspersen C.J. Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc 2000, 48:883-893.